Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET
Clinical trial NCT02850302 · COMPLETED
Trial details
- NCT number
- NCT02850302
- Sponsor
- Centre Georges Francois Leclerc
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-08
- Primary completion
- 2016-11-08
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.